Evidence map›Paper›PMID 27352628›Full record

SynthesisInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2016

Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis.

Alaa Badawi, Seung Gwan Ryoo

Registry-linked trialOpen access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04459390 (Impact of Comorbidities on COVID19 Outcome), which is not on this map. Cited by 388 papers, 17 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
388citing papers in PubMed, 17 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04459390 unknown statusnot on this mapstarted 2020, after this paper: background citation

Impact of Comorbidities on COVID19 Outcome

TypeobservationalSponsorAssiut UniversityRan2020 to 2020Enrolled100ConditionsCOVID19Armsrealtime PCR
3 · Its place in the literature

Who cites it

388 citing papers in PubMed, 17 syntheses or guidelines pooled it, 748 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Systematic Review of COVID-19 Related Myocarditis: Insights on Management and Outcome.Cardiovascular revascularization medicine : including molecular interventions · 2021
    Pooled it
  13. A Mixed-Methods Systematic Review of the Impacts of Coronavirus on Society and Culture.International journal of environmental research and public health · 2021
    Pooled it
  14. Pooled it
  15. Pooled it
  16. Pooled it
  17. Pooled it
  18. Trial
  19. Review
  20. Review

328 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Alaa BadawiPublic Health Risk Science Division, Public Health Agency of Canada, 180 Queen Street West, Toronto, ON M5V 3L7, Canada. Electronic address: alaa.badawi@phac-aspc.gc.ca.
Seung Gwan RyooFaculty of Arts and Science, University of Toronto, Toronto, ON, Canada.
Public Health Agency of Canada · CAUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Middle East respiratory syndrome coronavirus (MERS-CoV) is associated with life-threatening severe illnesses and a mortality rate of approximately 35%, particularly in patients with underlying comorbidities. A systematic analysis of 637 MERS-CoV cases suggests that diabetes and hypertension are equally prevalent in approximately 50% of the patients. Cardiac diseases are present in 30% and obesity in 16% of the cases. These conditions down-regulate the synthesis of proinflammatory cytokines and impair the host's innate and humoral immune systems. In conclusion, protection against MERS-CoV and other respiratory infections can be improved if public health vaccination strategies are tailored to target persons with chronic disorders.

Indexed as

ComorbidityCoronavirus InfectionsHumansMaleMiddle East Respiratory Syndrome CoronavirusPrevalenceCardiovascular diseasesDiabetes mellitusMiddle East respiratory syndrome coronavirus (MERS-CoV)ObesitySystematic review

Identifiers

PMID27352628
PMCPMC7110556
OpenAlexW2465777822

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.